AAA

ALPHAHELIX MOLECULAR DIAGNOSTICS AB

No trades
See on Supercharts
Market capitalization
‪21.94 M‬SEK
−0.150SEK
‪−9.48 M‬SEK
‪26.10 M‬SEK
‪46.82 M‬
Beta (1Y)
−0.94

About ALPHAHELIX MOLECULAR DIAGNOSTICS AB

CEO
Joakim Grånemo
Headquarters
Nacka
Employees (FY)
13
Founded
1998
ISIN
SE0000885501
FIGI
BBG001Y25PK2
AlphaHelix Molecular Diagnostics AB engages in the development, manufacturing, and marketing of instruments for deoxyribonucleic acid analysis. Its products include Clinical diagnostics, Extraction and purification, Biobank, General lab equipment, Next-generation sequencing, PCR, Cloning and Single-cell. The Company was founded in 1998 and is headquartered in Nacka, Sweden.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of ALPH is 0.346 SEK — it hasn't changed in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NGM exchange ALPHAHELIX MOLECULAR DIAGNOSTICS AB stocks are traded under the ticker ALPH.
ALPH stock is 14.57% volatile and has beta coefficient of −0.94. Check out the list of the most volatile stocks — is ALPHAHELIX MOLECULAR DIAGNOSTICS AB there?
Yes, you can track ALPHAHELIX MOLECULAR DIAGNOSTICS AB financials in yearly and quarterly reports right on TradingView.
ALPH stock has risen by 2.37% compared to the previous week, the month change is a 7.45% rise, over the last year ALPHAHELIX MOLECULAR DIAGNOSTICS AB has showed a 47.73% decrease.
ALPH net income for the last quarter is ‪−4.26 M‬ SEK, while the quarter before that showed ‪−2.30 M‬ SEK of net income which accounts for −85.22% change. Track more ALPHAHELIX MOLECULAR DIAGNOSTICS AB financial stats to get the full picture.
Today ALPHAHELIX MOLECULAR DIAGNOSTICS AB has the market capitalization of ‪21.94 M‬, it has increased by 21.83% over the last week.
No, ALPH doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, ALPH shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ALPHAHELIX MOLECULAR DIAGNOSTICS AB stock right from TradingView charts — choose your broker and connect to your account.
ALPH reached its all-time high on Sep 13, 2021 with the price of 3.656 SEK, and its all-time low was 0.190 SEK and was reached on Aug 18, 2011.
See other stocks reaching their highest and lowest prices.
As of Apr 25, 2024, the company has 13.00 employees. See our rating of the largest employees — is ALPHAHELIX MOLECULAR DIAGNOSTICS AB on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ALPHAHELIX MOLECULAR DIAGNOSTICS AB technincal analysis shows the buy rating today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ALPHAHELIX MOLECULAR DIAGNOSTICS AB stock shows the sell signal. See more of ALPHAHELIX MOLECULAR DIAGNOSTICS AB technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ALPHAHELIX MOLECULAR DIAGNOSTICS AB EBITDA is ‪−7.85 M‬ SEK, and current EBITDA margin is −31.49%. See more stats in ALPHAHELIX MOLECULAR DIAGNOSTICS AB financial statements.